PHIO
Phio Pharmaceuticals Corp.
NASDAQ · Healthcare · Biotechnology · US
$1.09
−1.80%3
Insider buys (3m)
0
Insider sells (3m)
$37.6K
Net value (3m)
+2.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 20, 2026 | Plott Ronald Todd · director | Purchase | 15,000 | $1.14 |
| Aug 19, 2026 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | Purchase | 10,000 | $1.06 |
| Jun 29, 2026 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | Purchase | 10,000 | $0.99 |
| Feb 6, 2026 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | A-Award | 120,000 | $0.00 |
| Feb 6, 2026 | Lockshin Curtis · director | A-Award | 16,600 | $0.00 |
| Feb 6, 2026 | Carson Lisa Cabott · officer: Chief Financial Officer | A-Award | 47,000 | $0.00 |
| Feb 6, 2026 | BRADFORD PATRICIA A · director | A-Award | 18,500 | $0.00 |
| Feb 6, 2026 | Freeman Jonathan E · director | A-Award | 16,600 | $0.00 |
| Feb 6, 2026 | Deming David H · director | A-Award | 23,800 | $0.00 |
| Jan 2, 2026 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.03 |
| Dec 29, 2025 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.02 |
| Nov 24, 2025 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.14 |
| Nov 19, 2025 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | Purchase | 5,000 | $1.27 |
| Sep 15, 2025 | Freeman Jonathan E · director | A-Award | 14,700 | $0.00 |
| Sep 15, 2025 | Ferrara Robert L · director | A-Award | 23,000 | $0.00 |
| Sep 15, 2025 | Carson Lisa Cabott · officer: VP, Finance and Administration | A-Award | 47,000 | $0.00 |
| Sep 15, 2025 | BRADFORD PATRICIA A · director | A-Award | 18,800 | $0.00 |
| Sep 15, 2025 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | A-Award | 250,000 | $0.00 |
| Sep 15, 2025 | Bitterman Robert J · director, officer: Chairman, Pres. & CEO | F-InKind | 4,111 | $2.32 |
| Sep 15, 2025 | Lockshin Curtis · director | A-Award | 16,200 | $0.00 |
| Sep 15, 2025 | Deming David H · director | A-Award | 14,000 | $0.00 |
| Sep 15, 2025 | Ferrara Robert L · director | A-Award | 23,100 | $0.00 |
| Jun 11, 2025 | Ferrara Robert L · director | Purchase | 2,500 | $2.42 |
| Jun 11, 2025 | Bitterman Robert J · director, officer: Chairman, Pres & CEO | Purchase | 2,000 | $2.42 |
| Jun 10, 2025 | Bitterman Robert J · director, officer: Chairman, Pres & CEO | Purchase | 1,500 | $2.75 |
| May 23, 2025 | Bitterman Robert J · director, officer: Chairman, Pres & CEO | Purchase | 1,200 | $1.78 |
| May 23, 2025 | Bitterman Robert J · director, officer: Chairman, Pres & CEO | Purchase | 3,000 | $1.77 |
| May 21, 2025 | Ferrara Robert L · director | Purchase | 2,500 | $1.82 |
| Sep 13, 2024 | Bitterman Robert J · director, officer: Chairman, Pres & CEO | A-Award | 15,500 | $0.00 |
| Sep 13, 2024 | Freeman Jonathan E · director | A-Award | 1,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 15Increased 5Reduced 1Sold out 24
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 147,254 | May 15, 2026 |
| JANE STREET GROUP, LLC | New Position | 119,189 | May 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 79,853 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 47,150 | Sep 2, 2026 |
| CETERA INVESTMENT ADVISERS | Increased | 45,000 | May 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 38,169 | May 8, 2026 |
| HRT FINANCIAL LP | New Position | 34,732 | May 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 32,495 | May 15, 2026 |
| SCIENTECH RESEARCH LLC | New Position | 30,032 | May 15, 2026 |
| UBS GROUP AG | Increased | 26,987 | May 5, 2026 |
| XTX TOPCO LTD | New Position | 24,868 | May 15, 2026 |
| NORTHERN TRUST CORP | Unchanged | 23,758 | May 14, 2026 |
| GSA CAPITAL PARTNERS LLP | New Position | 19,864 | May 8, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 15,224 | May 15, 2026 |
| CAPTRUST FINANCIAL ADVISORS | Unchanged | 10,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026